ERYTECH Reports Financial Highlights for Q4 2015 Post author:admERY Post published:January 11, 2016 Post category:Newsroom ERYTECH reports revenue and cash balance for the fourth quarter of 2015. You Might Also Like ERYTECH Granted U.S. FDA Fast Track Designation for eryaspase in Second-Line Pancreatic Cancer April 28, 2020 ERYTECH Announces Upcoming Poster Presentation at the 2021 American Society of Hematology Annual Meeting November 15, 2021 ERYTECH to hold Business Update and 2016 Financial Results Conference Call on March 3rd, 2017 February 28, 2017
ERYTECH Granted U.S. FDA Fast Track Designation for eryaspase in Second-Line Pancreatic Cancer April 28, 2020
ERYTECH Announces Upcoming Poster Presentation at the 2021 American Society of Hematology Annual Meeting November 15, 2021
ERYTECH to hold Business Update and 2016 Financial Results Conference Call on March 3rd, 2017 February 28, 2017
